Magnesium citrate
- Generic Name
- Magnesium citrate
- Brand Names
- Citroma
- Drug Type
- Small Molecule
- Chemical Formula
- C12H10Mg3O14
- CAS Number
- 3344-18-1
- Unique Ingredient Identifier
- RHO26O1T9V
- Background
Magnesium citrate is a low volume and osmotic cathartic agent. The cathartic action works primarily through the high osmolarity of the solution which draws large amounts of fluid into space where is used. Magnesium citrate is considered by the FDA as an approved inactive ingredient for approved drug products under the specifications of oral administration of...
- Indication
Magnesium citrate has been used in bowel preparations prior to a colonoscopy as a cathartic agent.
It is also used in over-the-counter products to relieve occasional constipation.
Magnesium citrate can be one of the forms used for the administration of dietary supplements.
- Associated Conditions
- Migraine
- Associated Therapies
- -
Better Evidence and Translation for Calciphylaxis
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- University of Sydney
- Target Recruit Count
- 350
- Registration Number
- NCT05018221
- Locations
- 🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia
🇦🇺Sunshine Hospital (Western Health), St Albans, Victoria, Australia
🇳🇿Tauranga Hospital, Tauranga, New Zealand
RELISTOR's Effects on Opioid-Induced Constipation
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- Methodist Health System
- Registration Number
- NCT04930237
- Locations
- 🇺🇸
Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center, Dallas, Texas, United States
A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy
- Conditions
- Interventions
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2020-07-23
- Target Recruit Count
- 3000
- Registration Number
- NCT02032186
- Locations
- 🇧🇷
Instituto de Medicina Integral Prof Fernando Figueira (IMIP), Recife, Pernambuco, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.